Nomascus leucogenys (northern white-cheeked gibbon): 100583968
Help
Entry
100583968 CDS
T03265
Symbol
TNF
Name
(RefSeq) tumor necrosis factor
KO
K03156
tumor necrosis factor superfamily, member 2
Organism
nle
Nomascus leucogenys (northern white-cheeked gibbon)
Pathway
nle01523
Antifolate resistance
nle04010
MAPK signaling pathway
nle04060
Cytokine-cytokine receptor interaction
nle04061
Viral protein interaction with cytokine and cytokine receptor
nle04064
NF-kappa B signaling pathway
nle04071
Sphingolipid signaling pathway
nle04150
mTOR signaling pathway
nle04210
Apoptosis
nle04217
Necroptosis
nle04350
TGF-beta signaling pathway
nle04380
Osteoclast differentiation
nle04612
Antigen processing and presentation
nle04620
Toll-like receptor signaling pathway
nle04621
NOD-like receptor signaling pathway
nle04622
RIG-I-like receptor signaling pathway
nle04625
C-type lectin receptor signaling pathway
nle04640
Hematopoietic cell lineage
nle04650
Natural killer cell mediated cytotoxicity
nle04657
IL-17 signaling pathway
nle04660
T cell receptor signaling pathway
nle04664
Fc epsilon RI signaling pathway
nle04668
TNF signaling pathway
nle04920
Adipocytokine signaling pathway
nle04930
Type II diabetes mellitus
nle04931
Insulin resistance
nle04932
Non-alcoholic fatty liver disease
nle04933
AGE-RAGE signaling pathway in diabetic complications
nle04936
Alcoholic liver disease
nle04940
Type I diabetes mellitus
nle05010
Alzheimer disease
nle05014
Amyotrophic lateral sclerosis
nle05020
Prion disease
nle05022
Pathways of neurodegeneration - multiple diseases
nle05132
Salmonella infection
nle05133
Pertussis
nle05134
Legionellosis
nle05135
Yersinia infection
nle05140
Leishmaniasis
nle05142
Chagas disease
nle05143
African trypanosomiasis
nle05144
Malaria
nle05145
Toxoplasmosis
nle05146
Amoebiasis
nle05152
Tuberculosis
nle05160
Hepatitis C
nle05161
Hepatitis B
nle05163
Human cytomegalovirus infection
nle05164
Influenza A
nle05165
Human papillomavirus infection
nle05166
Human T-cell leukemia virus 1 infection
nle05168
Herpes simplex virus 1 infection
nle05169
Epstein-Barr virus infection
nle05170
Human immunodeficiency virus 1 infection
nle05171
Coronavirus disease - COVID-19
nle05205
Proteoglycans in cancer
nle05310
Asthma
nle05321
Inflammatory bowel disease
nle05322
Systemic lupus erythematosus
nle05323
Rheumatoid arthritis
nle05330
Allograft rejection
nle05332
Graft-versus-host disease
nle05410
Hypertrophic cardiomyopathy
nle05414
Dilated cardiomyopathy
nle05417
Lipid and atherosclerosis
nle05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
nle00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100583968 (TNF)
04350 TGF-beta signaling pathway
100583968 (TNF)
04064 NF-kappa B signaling pathway
100583968 (TNF)
04668 TNF signaling pathway
100583968 (TNF)
04071 Sphingolipid signaling pathway
100583968 (TNF)
04150 mTOR signaling pathway
100583968 (TNF)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
100583968 (TNF)
04061 Viral protein interaction with cytokine and cytokine receptor
100583968 (TNF)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100583968 (TNF)
04217 Necroptosis
100583968 (TNF)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
100583968 (TNF)
04620 Toll-like receptor signaling pathway
100583968 (TNF)
04621 NOD-like receptor signaling pathway
100583968 (TNF)
04622 RIG-I-like receptor signaling pathway
100583968 (TNF)
04625 C-type lectin receptor signaling pathway
100583968 (TNF)
04650 Natural killer cell mediated cytotoxicity
100583968 (TNF)
04612 Antigen processing and presentation
100583968 (TNF)
04660 T cell receptor signaling pathway
100583968 (TNF)
04657 IL-17 signaling pathway
100583968 (TNF)
04664 Fc epsilon RI signaling pathway
100583968 (TNF)
09152 Endocrine system
04920 Adipocytokine signaling pathway
100583968 (TNF)
09158 Development and regeneration
04380 Osteoclast differentiation
100583968 (TNF)
09160 Human Diseases
09161 Cancer: overview
05205 Proteoglycans in cancer
100583968 (TNF)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100583968 (TNF)
05170 Human immunodeficiency virus 1 infection
100583968 (TNF)
05161 Hepatitis B
100583968 (TNF)
05160 Hepatitis C
100583968 (TNF)
05171 Coronavirus disease - COVID-19
100583968 (TNF)
05164 Influenza A
100583968 (TNF)
05168 Herpes simplex virus 1 infection
100583968 (TNF)
05163 Human cytomegalovirus infection
100583968 (TNF)
05169 Epstein-Barr virus infection
100583968 (TNF)
05165 Human papillomavirus infection
100583968 (TNF)
09171 Infectious disease: bacterial
05132 Salmonella infection
100583968 (TNF)
05135 Yersinia infection
100583968 (TNF)
05133 Pertussis
100583968 (TNF)
05134 Legionellosis
100583968 (TNF)
05152 Tuberculosis
100583968 (TNF)
09174 Infectious disease: parasitic
05146 Amoebiasis
100583968 (TNF)
05144 Malaria
100583968 (TNF)
05145 Toxoplasmosis
100583968 (TNF)
05140 Leishmaniasis
100583968 (TNF)
05142 Chagas disease
100583968 (TNF)
05143 African trypanosomiasis
100583968 (TNF)
09163 Immune disease
05310 Asthma
100583968 (TNF)
05322 Systemic lupus erythematosus
100583968 (TNF)
05323 Rheumatoid arthritis
100583968 (TNF)
05321 Inflammatory bowel disease
100583968 (TNF)
05330 Allograft rejection
100583968 (TNF)
05332 Graft-versus-host disease
100583968 (TNF)
09164 Neurodegenerative disease
05010 Alzheimer disease
100583968 (TNF)
05014 Amyotrophic lateral sclerosis
100583968 (TNF)
05020 Prion disease
100583968 (TNF)
05022 Pathways of neurodegeneration - multiple diseases
100583968 (TNF)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100583968 (TNF)
05418 Fluid shear stress and atherosclerosis
100583968 (TNF)
05410 Hypertrophic cardiomyopathy
100583968 (TNF)
05414 Dilated cardiomyopathy
100583968 (TNF)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100583968 (TNF)
04940 Type I diabetes mellitus
100583968 (TNF)
04936 Alcoholic liver disease
100583968 (TNF)
04932 Non-alcoholic fatty liver disease
100583968 (TNF)
04931 Insulin resistance
100583968 (TNF)
04933 AGE-RAGE signaling pathway in diabetic complications
100583968 (TNF)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
100583968 (TNF)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
nle04052
]
100583968 (TNF)
00536 Glycosaminoglycan binding proteins [BR:
nle00536
]
100583968 (TNF)
Cytokines and neuropeptides [BR:
nle04052
]
Cytokines
Tumor necrosis fators
100583968 (TNF)
Glycosaminoglycan binding proteins [BR:
nle00536
]
Heparan sulfate / Heparin
Cytokines
100583968 (TNF)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
TNF
Motif
Other DBs
NCBI-GeneID:
100583968
NCBI-ProteinID:
XP_003272142
Ensembl:
ENSNLEG00000028057
UniProt:
A0A2I3HVV8
LinkDB
All DBs
Position
22a:52604482..52607247
Genome browser
AA seq
233 aa
AA seq
DB search
MSTESMIRDVELAEEALPKKTGGPQGSRRCFLLSLFSFLLVAGATTLFCLLHFGVIGPQR
EEFPKDLPLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVQLT
DNQLVVPSEGLYLIYSQVLFKGQGCPPTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRE
TPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL
NT seq
702 nt
NT seq
+upstream
nt +downstream
nt
atgagcactgaaagcatgatccgggacgtggagctggctgaggaggcgctccccaagaag
acaggggggccccagggctccaggcggtgctttctcctcagcctcttctccttcctgctc
gtggcaggcgccaccacgctcttctgcctgctgcactttggagtgatcggcccacagagg
gaagagttccccaaggacctccctctaatcagccctctggcccaggcagtcagatcatct
tctcgaaccccgagtgacaagcctgtagcccatgttgtagcaaaccctcaagctgagggg
cagctccagtggctgaaccgccgggccaatgccctcctggccaatggcgtgcagctgaca
gataaccagctggtggtgccatcagagggcctgtacctcatctactcccaggtcctcttc
aagggccaaggctgcccccccacccatgtgctcctcacccacaccatcagccgcatcgcc
gtctcctaccagaccaaggtcaacctcctctctgccatcaagagcccctgccagagggag
accccagagggggctgaggccaagccctggtatgagcccatctatctgggaggggtattc
cagctggagaagggtgatcgactcagcgctgagatcaatcggcctgactatctcgacttt
gccgagtctgggcaggtctacttcgggatcattgccctgtga
DBGET
integrated database retrieval system